Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Global Sales Information
Company : Amgen
Romosozumab-Aqqg
Drug Cost (USD) : 1,024,894
Year : 2023
Prescribers : 145
Prescriptions : 440

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Romosozumab-Aqqg
Drug Cost (USD) : 71,634,311
Year : 2023
Prescribers : 6219
Prescriptions : 28510

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Romosozumab-Aqqg
Drug Cost (USD) : 363,407
Year : 2022
Prescribers : 68
Prescriptions : 172

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Romosozumab-Aqqg
Drug Cost (USD) : 50,051,726
Year : 2022
Prescribers : 4513
Prescriptions : 21843

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Romosozumab-Aqqg
Drug Cost (USD) : 99,694
Year : 2021
Prescribers : 23
Prescriptions : 51

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Romosozumab-Aqqg
Drug Cost (USD) : 29,030,405
Year : 2021
Prescribers : 3003
Prescriptions : 13840

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Romosozumab-Aqqg
Drug Cost (USD) : 73,487
Year : 2020
Prescribers : 21
Prescriptions : 39

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Romosozumab-Aqqg
Drug Cost (USD) : 14,428,059
Year : 2020
Prescribers : 1569
Prescriptions : 7353

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Romosozumab-Aqqg
Drug Cost (USD) : 17,539
Year : 2019
Prescribers :
Prescriptions : 11

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Romosozumab-Aqqg
Drug Cost (USD) : 3,305,412
Year : 2019
Prescribers : 593
Prescriptions : 1690

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Main Therapeutic Indication : Musculoskeletal
Currency : USD
2020 Revenue in Millions : 350
2019 Revenue in Millions : 189
Growth (%) : 85

Main Therapeutic Indication : Musculoskeletal
Currency : USD
2020 Revenue in Millions : 240
2019 Revenue in Millions : 157
Growth (%) : 53

Main Therapeutic Indication : Musculoskeletal
Currency : USD
2021 Revenue in Millions : 246
2020 Revenue in Millions : 238
Growth (%) : 11

Main Therapeutic Indication : Musculoskeletal
Currency : USD
2020 Revenue in Millions : 2
2019 Revenue in Millions : 0
Growth (%) : New Launch

Main Therapeutic Indication : Musculoskeletal
Currency : USD
2021 Revenue in Millions : 530
2020 Revenue in Millions : 350
Growth (%) : 51

Main Therapeutic Indication : Musculoskeletal
Currency : USD
2021 Revenue in Millions : 11
2020 Revenue in Millions : 2
Growth (%) : 400

Main Therapeutic Indication : Musculoskeletal
Currency : USD
2022 Revenue in Millions : 302
2021 Revenue in Millions : 265
Growth (%) : 14

Main Therapeutic Indication : Musculoskeletal
Currency : USD
2022 Revenue in Millions : 787
2021 Revenue in Millions : 530
Growth (%) : 48

Main Therapeutic Indication : Musculoskeletal
Currency : USD
2022 Revenue in Millions : 27
2021 Revenue in Millions : 11
Growth (%) : 142

Main Therapeutic Indication : Musculoskeletal
Currency : USD
2023 Revenue in Millions : 1,160
2022 Revenue in Millions : 787
Growth (%) : 47

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Reply
02 Aug 2022

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Patents & EXCLUSIVITIES
ABOUT THIS PAGE